PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
China · Delayed Price · Currency is CNY 45.49
+1.09 (2.45%)
At close: May 12, 2026
SHE:301230 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 46.1 | 34.29 | 17.08 | 37.62 | 67.18 | 73.58 |
Depreciation & Amortization | 51.48 | 51.48 | 48.81 | 35.53 | 28.4 | 24.07 |
Other Amortization | 42.97 | 42.97 | 28.83 | 13 | 9.26 | 2.68 |
Loss (Gain) From Sale of Assets | -0.04 | -0.04 | - | -0.01 | - | -0.05 |
Asset Writedown & Restructuring Costs | 5.19 | 5.19 | 0.29 | 0.71 | 0.07 | 2.55 |
Loss (Gain) From Sale of Investments | -0.11 | -0.11 | -8.41 | -6.21 | -0.5 | -1.8 |
Provision & Write-off of Bad Debts | - | - | 1.27 | 0.3 | -0.31 | 2.46 |
Other Operating Activities | 30.31 | 10.49 | 3.83 | 18.13 | -0.77 | 4.25 |
Change in Accounts Receivable | -16.79 | -16.79 | 7.11 | -51.12 | -8.99 | -60.22 |
Change in Inventory | -16.89 | -16.89 | -4.37 | -18.29 | -6.37 | 13.39 |
Change in Accounts Payable | 34.33 | 34.33 | 7.25 | -7.84 | -1.77 | 33.55 |
Change in Other Net Operating Assets | 6.12 | 6.12 | - | 5.4 | 11.45 | 11.45 |
Operating Cash Flow | 167.14 | 135.51 | 80.86 | 20.86 | 99.29 | 105.12 |
Operating Cash Flow Growth | 139.75% | 67.58% | 287.68% | -78.99% | -5.55% | 93.06% |
Capital Expenditures | -54.3 | -43.32 | -109.4 | -248.27 | -123.97 | -92.12 |
Sale of Property, Plant & Equipment | 0.12 | 0.12 | 0.15 | 0.01 | - | 0.06 |
Investment in Securities | 5.72 | -0.3 | 61 | -339.97 | -7.99 | 1.8 |
Other Investing Activities | 6.85 | 0.11 | 3.44 | 5.94 | 0.15 | - |
Investing Cash Flow | -41.6 | -43.39 | -44.82 | -582.28 | -131.81 | -90.25 |
Short-Term Debt Issued | - | - | 19.65 | 15.91 | 12.24 | 26.24 |
Long-Term Debt Issued | - | 25.66 | - | - | - | - |
Total Debt Issued | 18.01 | 25.66 | 19.65 | 15.91 | 12.24 | 26.24 |
Short-Term Debt Repaid | - | - | -25.56 | -10 | -24.55 | -26.56 |
Long-Term Debt Repaid | - | -25.66 | -29.34 | -23.28 | -14.28 | -9.39 |
Total Debt Repaid | -25.66 | -25.66 | -54.91 | -33.28 | -38.84 | -35.94 |
Net Debt Issued (Repaid) | -7.65 | - | -35.25 | -17.37 | -26.59 | -9.7 |
Issuance of Common Stock | - | - | - | - | 710 | - |
Common Dividends Paid | -66.24 | -54.04 | -49.27 | -38.82 | -0.78 | -0.78 |
Dividends Paid | -66.24 | -54.04 | -49.27 | -38.82 | -0.78 | -0.78 |
Other Financing Activities | -27.11 | -25.82 | -53.08 | - | - | - |
Financing Cash Flow | -101.01 | -79.87 | -137.61 | -56.19 | 682.62 | -10.48 |
Foreign Exchange Rate Adjustments | -1.06 | 1.82 | 4.82 | -0.54 | 7.78 | -2.11 |
Net Cash Flow | 23.46 | 14.07 | -96.75 | -618.15 | 657.89 | 2.28 |
Free Cash Flow | 112.84 | 92.2 | -28.54 | -227.41 | -24.67 | 13.01 |
Free Cash Flow Growth | - | - | - | - | - | -37.90% |
Free Cash Flow Margin | 16.32% | 13.39% | -5.24% | -46.44% | -5.15% | 2.90% |
Free Cash Flow Per Share | 0.78 | 0.65 | -0.20 | -1.63 | -0.22 | 0.12 |
Cash Income Tax Paid | 9.63 | 9.01 | 5.17 | -2.53 | -4.43 | 11.2 |
Levered Free Cash Flow | 55.69 | 59.12 | -136.91 | -130.96 | -48.28 | -7.85 |
Unlevered Free Cash Flow | 55.69 | 59.12 | -131.11 | -127.54 | -45.29 | -6.26 |
Change in Working Capital | -8.77 | -8.77 | -10.84 | -78.22 | -4.02 | -2.61 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.